Related Experiment Video
Updated: May 5, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
PPAR-γ agonist stabilizes KLF4 protein via activating Akt signaling and reducing KLF4 ubiquitination
Yan Sun1, Bin Zheng1, Xin-hua Zhang1
1Department of Biochemistry and Molecular Biology, The Key Laboratory of Neural and Vascular Biology, China Administration of Education, Hebei Medical University, No. 361 Zhongshan East Road, Shijiazhuang 050017, China.
Abstract:
Peroxisome proliferator activated receptor γ (PPAR-γ) plays important roles in cell cycle regulation, differentiation and apoptosis. Krüppel-like factor 4 (KLF4) modulates vascular smooth muscle cell (VSMC) phenotype. Both KLF4 and PPAR-γ are involved in VSMC proliferation and differentiation. However, the actual relationship between KLF4 and PPAR-γ in VSMCs is not clear. In this study, we found that PPAR-γ agonist pioglitazone increases KLF4 protein levels but does not influence KLF4 gene transcription. PPAR-γ overexpression increases, while PPAR-γ knockdown reduces KLF4 expression, suggesting that the increase in KLF4 protein levels induced by pioglitazone is PPAR-γ-dependent. Further study showed that pioglitazone enhances KLF4 protein stability through reducing KLF4 ubiquitination. Furthermore, we demonstrated that stabilization of KLF4 by pioglitazone was related to the activation of Akt signaling pathway. Taken together, we revealed that PPAR-γ agonist pioglitazone stabilizes KLF4 protein via activating Akt signaling and reducing KLF4 ubiquitination, providing further insights into PPAR-γ and KLF4 in regulating each other's expression in VSMCs.
Insights
The PPAR-γ agonist pioglitazone increases Krüppel-like factor 4 (KLF4) protein levels in vascular smooth muscle cells by enhancing KLF4 protein stability. This process involves the Akt signaling pathway and reduced KLF4 ubiquitination.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Peroxisome proliferator activated receptor γ (PPAR-γ) is crucial for cell cycle regulation, differentiation, and apoptosis.
- Krüppel-like factor 4 (KLF4) influences vascular smooth muscle cell (VSMC) phenotype.
- Both PPAR-γ and KLF4 are implicated in VSMC proliferation and differentiation, but their direct relationship remains unclear.
Purpose of the Study:
- To elucidate the relationship between PPAR-γ and KLF4 in VSMCs.
- To investigate the mechanism by which PPAR-γ affects KLF4 expression.
Main Methods:
- Treatment of VSMCs with PPAR-γ agonist pioglitazone.
- Assessment of KLF4 protein and gene expression.
- PPAR-γ overexpression and knockdown experiments.
- Analysis of KLF4 ubiquitination and protein stability.
- Investigation of Akt signaling pathway activation.
Main Results:
- Pioglitazone increased KLF4 protein levels without affecting KLF4 gene transcription.
- PPAR-γ activation was essential for the pioglitazone-induced increase in KLF4.
- Pioglitazone enhanced KLF4 protein stability by reducing its ubiquitination.
- This stabilization was linked to the activation of the Akt signaling pathway.
Conclusions:
- PPAR-γ agonist pioglitazone stabilizes KLF4 protein in VSMCs.
- The mechanism involves Akt signaling activation and decreased KLF4 ubiquitination.
- This study provides new insights into the cross-regulation of PPAR-γ and KLF4 in VSMCs.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization
cAMP-dependent Protein Kinase Pathways

